Announcements

In light of the current COVID-19 pandemic and the resultant closures of businesses and non-essential operations by many state governments, AATB would like to emphasize that tissue banks are an essential health care operation.

*Updated 4/23/20

After much consideration and discussion, the American Association of Tissue Banks has made the difficult decision to cancel the 2020 Quality & Donor Eligibility Workshop scheduled for April 6-8, 2020, in Portland, OR.

Previously referred to as 2019-nCoV, the infectious disease caused by the Novel Coronavirus identified in December 2019 has now been assigned the name “COVID-19” by the WHO, to include all forms of the disease from mild to severe.

On behalf of our membership, AATB provided comment on the Centers for Medicare and Medicaid Services (CMS) proposed rule addressing Organ Procurement Organizations (OPOs) Conditions for Coverage and Outcome Measure Requirements (Proposed Rule).

On behalf of our membership, AATB filed a Citizen Petition to the Food and Drug Administration (FDA) related to the use of human acellular dermal matrices (hADM) for use in post-mastectomy breast reconstruction procedures.

Tissue recipient, Jim Vidas, will be representing AATB as a rider on the 2020 Donate Life Rose Parade Float. Jim was nominated for this opportunity by Washington Regional Transplant Community, an AATB-accredited organization based outside of Washington, DC.

AATB is pleased to announce that tissue recipient, Bill Bourbeau, has been selected to represent AATB as a rider on the 2019 Donate Life Rose Parade Float.

In order to accurately articulate the size, scope, and positive clinical impact of the tissue banking profession, AATB conducted a survey of US tissue banks in partnership with the US Department of Health and Human Services.